<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ARID1B</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>ARID1B</td>
</tr>
<tr>
<td class="label">HGNC ID</td>
<td>18040</td>
</tr>
<tr>
<td class="label">Entrez ID</td>
<td>57492</td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td>ENSG00000049618</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>6q25.3</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein-coding</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>[ARID1B protein](/proteins/arid1b-protein)</td>
</tr>
<tr>
<td class="label">Key Domains</td>
<td>ARID, DUF3518, C-terminal EHD</td>
</tr>
<tr>
<td class="label">Function</td>
<td>BAF chromatin remodeling complex subunit</td>
</tr>
<tr>
<td class="label">Disease Associations</td>
<td>[Alzheimer's disease](/diseases/alzheimers-disease), Coffin-Siris syndrome type 1, intellectual disability</td>
</tr>
<tr>
<td class="label">Variant</td>
<td>Type</td>
</tr>
<tr>
<td class="label">>150 LoF variants</td>
<td>Truncating/frameshift</td>
</tr>
<tr>
<td class="label">De novo LoF variants</td>
<td>Various</td>
</tr>
<tr>
<td class="label">Common enhancer variants</td>
<td>Regulatory</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ARID1B</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>ARID1B</td>
</tr>
<tr>
<td class="label">HGNC ID</td>
<td>18040</td>
</tr>
<tr>
<td class="label">Entrez ID</td>
<td>57492</td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td>ENSG00000049618</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>6q25.3</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein-coding</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>[ARID1B protein](/proteins/arid1b-protein)</td>
</tr>
<tr>
<td class="label">Key Domains</td>
<td>ARID, DUF3518, C-terminal EHD</td>
</tr>
<tr>
<td class="label">Function</td>
<td>BAF chromatin remodeling complex subunit</td>
</tr>
<tr>
<td class="label">Disease Associations</td>
<td>[Alzheimer's disease](/diseases/alzheimers-disease), Coffin-Siris syndrome type 1, intellectual disability</td>
</tr>
<tr>
<td class="label">Variant</td>
<td>Type</td>
</tr>
<tr>
<td class="label">>150 LoF variants</td>
<td>Truncating/frameshift</td>
</tr>
<tr>
<td class="label">De novo LoF variants</td>
<td>Various</td>
</tr>
<tr>
<td class="label">Common enhancer variants</td>
<td>Regulatory</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
<div style="border:1px solid #aaa; background:#f9f9f9; padding:10px; width:300px; float:right; margin:0 0 10px 10px; font-size:0.9em;">
ARID1B (AT-Rich Interaction Domain 1B)
</div>
ARID1B is a human gene. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.
ARID1B (AT-Rich Interaction Domain 1B), also known as BAF250B, encodes a subunit of the BAF (BRG1/BRM-Associated Factor) [chromatin remodeling](/mechanisms/chromatin-remodeling-neurodegeneration) complex. ARID1B is mutually exclusive with [ARID1A](/genes/arid1a) in the canonical BAF (cBAF) complex, generating functionally distinct subcomplexes. ARID1B is the most commonly mutated gene in Coffin-Siris syndrome and among the most frequently mutated genes in intellectual disability. In the aging brain, ARID1B-containing BAF complexes play specialized roles in neuronal maintenance and neuroprotection, with implications for [Alzheimer's disease](/diseases/alzheimers-disease) and age-related cognitive decline.[@hoyer2012]
The ARID1B gene spans approximately 475 kb on chromosome 6q25.3 and contains 20 exons encoding a 2236-amino acid protein. ARID1B shows a more restricted expression pattern than [ARID1A](/genes/arid1a), with particularly high expression in the developing and adult brain. During cortical development, ARID1B expression peaks during neurogenesis and is maintained at lower levels in mature [neurons](/entities/neurons).
In the adult human brain, ARID1B is expressed across all regions, with the highest levels in the [hippocampus](/brain-regions/hippocampus), amygdala, and cortical association areas. Single-cell transcriptomics reveal predominant expression in excitatory and inhibitory neurons, with lower levels in glial cells. Notably, ARID1B expression is relatively preserved in the aging brain compared to [ARID1A](/genes/arid1a), suggesting a compensatory role in maintaining chromatin accessibility during aging.
ARID1B serves as an alternative specificity subunit of the canonical BAF (cBAF) complex, defining a distinct subcomplex (ARID1B-cBAF) with different genomic targeting compared to ARID1A-cBAF. Key functional features include:
The ARID1A/ARID1B switch during development represents a critical transition: neural progenitors express both paralogs, while postmitotic neurons increasingly rely on ARID1B-cBAF for maintaining neuronal gene expression programs.[@lessard2007][@mashtalir2018]
ARID1B is implicated in AD through several mechanisms:
Heterozygous loss-of-function variants in ARID1B are the most common cause of Coffin-Siris syndrome (type 1), accounting for approximately 68% of genetically confirmed cases. Features include:
The following diagram shows the key molecular relationships involving ARID1B discovered through SciDEX knowledge graph analysis: